Novus Therapeutics, Inc. is a clinical-stage public biotechnology company headquartered in Irvine, California, focused on the acquisition and development of pharmaceutical and therapeutic products.
Subscribe to see Novus Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Novus Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $109.9M across the 3 funding rounds on record. Its most recent funding round raised $108.1M in September 2020. Xcout tracks 12 named people at Novus Therapeutics, Inc., including David-Alexandre C. Gros (Chief Executive Officer).
6 more named people on record for Novus Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
At least $109.9M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $108.1M | — | |
| SEC Form D filing | $862,278 | — | |
| SEC Form D filing | $862,278 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Novus Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Ambros Therapeutics is a clinical-stage biotechnology company headquartered in Irvine, California, focused on the development of innovative therapeutics.
Novoron Bioscience, Inc. is a San Diego-based biotechnology company developing novel therapeutics to address central nervous system and other conditions.
Cellics Therapeutics, Inc. is a privately held biotechnology company headquartered in San Diego, California, developing novel therapeutic products.
Notable Labs, Inc. is a clinical-stage therapeutic platform company headquartered in Foster City, California. The company focuses on drug pipelines, patents, and clinical trials, and operates as a public company traded on NASDAQ under the ticker NTBL.
Eumentis Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to developing novel therapies for serious neuropsychiatric conditions.
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and autoimmune diseases. Headquartered in California, the company advances a robust clinical pipeline and operates as a publicly traded enterprise.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.